venture – Talk Bio

Dispatch Bio Launches with $216M and CAR-T Pioneer Carl June to Advance Universal Solid Tumor Immunotherapy

2 days ago talkbio0Tagged Arch of foot, Cancer Therapeutic Procedure, CAR-T, Carl June, Dispatch Bio, Flare platform, Funding, Immunotherapy, Parker Institute for Cancer Immunotherapy, Partner in relationship, Series, Solid Neoplasm, venture

Dispatch Bio; solid tumors; immunotherapy; CAR-T; Carl June; Series A funding; Flare platform; Parker Institute for Cancer Immunotherapy; ARCH Venture Partners; universal cancer treatment

Novartis Gains World-First Approval of Malaria Treatment for Babies

2 weeks ago talkbio0Tagged Africa, Approved, artemether-lumefantrine, Coartem, Infant, Infant, Newborn, Malaria, Novartis, Swissmedic, venture

Novartis; malaria; Coartem Baby; Swissmedic; newborns; infants; Africa; approval; artemether-lumefantrine; Medicines for Malaria Venture; not-for-profit

Sofinnova Partners Launches Three New Biotechs with €165M Acceleration Fund

4 months ago talkbio0Tagged Acceleration, BioClec, Funds, Partner in relationship, pharmaceutical backing, Sofinnova, venture

Sofinnova Partners, biotech acceleration fund, BioClec, Forth Therapeutics, Signadori Bio, venture capital, pharmaceutical backing

Sofinnova Partners Secures €1.2 Billion for Life Sciences Innovation

5 months ago talkbio0Tagged Capital, digital medicine, Health care facility, Industry, medtech, sustainability, venture

Venture capital, biotech, medtech, digital medicine, industrial biotech, healthcare, sustainability

New year starts with a bang as trio of venture financings brings in $382M

6 months ago talkbio0Tagged biotech, Capital, Investments, Life, Megarounds, Private financing, Tenvie, venture

Venture capital, Biotech funding, Megarounds, Tenvie Therapeutics, Private financing, Life sciences investments

Ouro Medicines Launches with $120M Funding to Develop Immune Reset Therapeutics for Chronic Immune-Mediated Diseases

6 months ago talkbio0Tagged Capital, Chronic Immune-Mediated Diseases, engagers, immune reset, innovations, Monograph, NEA, Norwest, Ouro Medicines, Partner in relationship, SmithKline Beecham, T-Lymphocyte, TPG, venture

Ouro Medicines, Immune Reset Therapeutics, Chronic Immune-Mediated Diseases, T Cell Engagers, B Cell Mediated Diseases, GSK, Monograph Capital, TPG Life Sciences Innovations, NEA, Norwest Venture Partners